STAAR Surgical's LASIK Alternative Expands U.S. Market Gains

MONROVIA, Calif., June 12 /PRNewswire-FirstCall/
-- STAAR Surgical Company (Nasdaq: STAA), a leading
developer, manufacture and marketer of minimally invasive
ophthalmic products, today announced that Visian ICL(TM)
(Implantable Collamer Lens) sales in the U.S. for the second
quarter have already exceeded the total sales for both the
first quarter of 2008 and the second quarter of 2007. The
company also announced the launch of its first viral
marketing initiative, a national consumer video competition,
"BEYOND LASIK - the Visian ICL(TM)," which will
begin with local contests driven by leading Visian ICL
surgeons throughout the U.S.

"The Visian ICL continues to expand its U.S. market
presence," said Barry G. Caldwell, President and CEO of
STAAR Surgical. "We have seen several factors contribute
to the Visian ICL's strong sales growth including new
media attention to the Visian ICL as an alternative for
LASIK, additional consumer awareness that not all
potential refractive patients are candidates for LASIK
and the Visian ICL Growth Program(TM) for
physicians and practice refractive administrators.

source: PR Newswire